A Case of Piperacillin-Induced Immune Thrombocytopenia: Diagnostic Challenges and Management

Drug-induced immune thrombocytopenia (DITP) is a rare yet critical disorder that requires prompt recognition and discontinuation of the causative drug to prevent severe complications. In DITP, platelet-reactive antibodies lead to significant platelet destruction. Heparin-induced thrombocytopenia is the most well-studied; yet, antibiotics have also been described. Herein is a case of a 97-year-old woman with a history of hypertension and hyperlipidemia who was admitted with rhabdomyolysis and sepsis secondary to choledocholithiasis and gallstone pancreatitis. She was started on intravenous fluids and broad-spectrum antibiotics, including piperacillin-tazobactam and vancomycin. Within days, her platelet count dropped from 323,000/μL to 1,000/μL. Schistocytes and hemolysis were absent on a peripheral smear. The patient had normal coagulation studies, and she had a low 4T (thrombocytopenia, timing of platelet count fall, thrombosis or other sequelae, and other causes for thrombocytopenia) score, ruling out thrombotic microangiopathies, such as disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), and heparin-induced thrombocytopenia (HIT), respectively. While immune thrombocytopenic purpura (ITP) was seriously considered, the temporal relationship between the drop in platelet count and the administration of broad-spectrum antibiotics led to greater suspicion of DITP. Piperacillin was suspected to be the cause and was promptly discontinued. The suspicion was subsequently confirmed, as supported by the detection of positive drug-dependent IgG antibodies. The patient's platelet count normalized within a week after stopping piperacillin and receiving IV immunoglobulin (1 g/kg). Hence, DITP needs to be considered among other causes in patients with acute severe thrombocytopenia, as early recognition and prompt cessation of the offending agent are important for preventing life-threatening hemorrhagic sequelae.

Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.

El resumen se deja sin traducir para conservar la redacción original de los autores.

A 97-year-old woman's platelet count fell from 323,000 to 1,000/μL within days of broad-spectrum antibiotics; a low 4T score excluded heparin-induced thrombocytopenia, drug-dependent IgG antibodies confirmed piperacillin as the cause, and counts normalized after discontinuation and IVIG.

Explore cómo esta investigación se conecta con la práctica clínica

Más estudios revisados por pares en la categoría «Ensayos clínicos».

• Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
• Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
• Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
• Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial — Abtahi-Forooshani M et al. (2026)
• Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report — Velasco-Bustamante J et al. (2026)
• Investigación de los efectos terapéuticos del tratamiento con sanguijuelas medicinales sobre la lesión por isquemia-reperfusión de la extremidad inferior — Ünal K et al. (2026)
• Efficacy of Medicinal Leech Therapy in Diverse Clinical Applications: A Comprehensive Study from Azerbaijan — Farzali S et al. (2025)
• HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW — Heinz P et al. (2020)
• Hirudoterapia en la cicatrización de heridas — Nair H et al. (2022)
• Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)

Ver toda la investigación analizada por la ASH →